Home Tags Psych Congress

Tag: Psych Congress

Study: California medical marijuana programs attracted past users

12/5/19--Results from a prevention study in California conducted by the RAND Corporation, published in the Journal of Studies on Alcohol and Drugs, suggest that medical marijuana programs in that state attracted a substantial number of young people who already were heavy users of the drug. Read

Congressional briefing calls for improved regulation of CBD

12/6/19--On Dec. 5, the National Association of County Behavioral Health & Developmental Disability Directors (NACBHDD), together with the National Association for Rural Mental Health (NARMH) and the National Association of Social Workers (NASW), hosted a Congressional briefing for Hill staff on the need for improved regulation of cannabidiol (CBD) products by the Food and Drug Administration (FDA). Read

Drug-induced psychoses may signal substantial schizophrenia risk

11/6/19--More than a third of people who experienced psychosis with cannabis use later transitioned to schizophrenia, according to a systematic review and meta-analysis published online in Schizophrenia Bulletin. Read

Cannabinoids not justified as mental health treatment, study says

11/4/19--A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances. Read